Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Articles published by Psycheceutical Bioscience, Inc.
Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab
March 29, 2023
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD
March 21, 2023
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD
February 15, 2023
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
February 02, 2023
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
January 26, 2023
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
January 10, 2023
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
November 29, 2022
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
October 18, 2022
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
October 04, 2022
From
Psycheceutical Bioscience, Inc.
Via
GlobeNewswire
Tickers
BWVI
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.